Vitiligo Drugs Market Analysis | CMI - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Vitiligo Drugs Market Analysis | CMI

Description:

Read here the latest updates on the Vitiligo Drugs Market Analysis published by CMI team – PowerPoint PPT presentation

Number of Views:1
Date added: 18 September 2020
Slides: 14
Provided by: Shweta2707
Category: Other

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Vitiligo Drugs Market Analysis | CMI


1
  • Coherent Market Insights
  • Market Research and Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • COVID-19 Impact Tracker

2
VITILIGO DRUGS MARKET ANALYSIS
  • Vitiligo Drugs Market, by Drug Class (Calcineurin
    Inhibitors, Corticosteroids, and Psoralens), by
    Type (Segmental and Non-segmental), by Route of
    Administration (Oral and Topical), by
    Distribution Channel (Hospital Pharmacies, Retail
    Pharmacies, and Online Pharmacies), and by Region
    (North America, Latin America, Europe, Asia
    Pacific, Middle East, and Africa) - Size, Share,
    Outlook, and Opportunity Analysis 2018 2026
  • The global vitiligo drugs market size was valued
    at US 120.6 million in 2017, and is expected to
    exhibit a CAGR of 8.4 over the forecast period
    (20182026).

3
Figure 1. Global Vitiligo Drugs Market Value (US
Mn), by Region, 2018
4
Market Drivers
  • Increasing prevalence and incidence of vitiligo
    is expected to propel the global Vitiligo Drugs
    Market growth
  • Vitiligo causes loss of skin color in spots. It
    can affect the skin on any part of the body,
    hair, and the inside of the mouth. Treatment for
    vitiligo can restore the color to the affected
    spot on the skin. However, it cannot completely
    prevent skin discoloration. According to the
    American Academy of Dermatology, 2017, the
    prevalence of vitiligo is approximately 1 in the
    U.S. and Europe.
  • Vitiligo is listed among 24 skin diseases
    examined in the Burden of Skin Disease report
    commissioned by the American Academy of
    Dermatology. Moreover, according to reports
    published by the American Academy of Dermatology
    in 2017, over 150,000 patient were treated for
    vitiligo during 2013 in the U.S. According to a
    study published in the National Center for
    Biotechnology Information (NCBI), in October
    2017, an estimated 0.5-1 of the global
    population was diagnosed with vitiligo.
    Furthermore, in the same year, approximately 8.8
    of Indias population and 0.38 of Denmarks
    population was diagnosed with vitiligo.
  • Therefore, increasing worldwide prevalence of
    vitiligo is expected to aid in growth of the
    global vitiligo drugs market over the forecast
    period.

5
Market Restraints
  • However, availability of advanced technologies
    and alternative therapies for vitiligo treatment
    is expected to restrain growth of the vitiligo
    drugs market during the forecast period. For
    instance, in October 2018, STRATA Skin Sciences,
    a manufacturer of innovative products for the
    treatment of skin conditions, announced the
    launch of XTRAC S3 308nm Laser at the American
    Society for Dermatologic Surgery Meeting. The
    XTRAC S3 308nm Laser is used for the treatment of
    skin disorders such as psoriasis and vitiligo.
    The XTRAC laser utilizes therapeutic UVB light
    for the treatment of affected skin areas without
    damaging surrounding healthy skin.

6
Figure 2. Global Vitiligo Drugs Market Share (),
by Drug Class
7
Market Opportunities
  • Increasing number of funding grants to accelerate
    development of effective treatment for vitiligo
    is expected to bolster the market growth
  • Increasing number of initiatives undertaken by
    various government organizations to develop novel
    treatments for vitiligo is expected to augment
    the market growth. For instance, in February
    2019, American Skin Association (ASA) announced
    funding for 18 new grants for skin cancer and
    disease research. The ASA and its affiliates
    invested over US 50 Mn for the treatment of
    melanoma, psoriasis, and vitiligo. Moreover,
    various government organizations are also focused
    on offering funds to accelerate development of
    effective treatment options for vitiligo, thereby
    augmenting the market growth. For instance, the
    Vitiligo Society in Europe funds research
    projects with the aim of establishing the real
    causes of vitiligo as well as developing
    effective and safe treatments for patients. The
    Society also supports and closely monitors
    research initiatives and is supported by a
    Medical and Scientific Advisory Panel.

8
Key Players
  • Major players operating in the global vitiligo
    drugs market include, Dermavant Sciences, Inc.,
    Incyte Corporation, Aclaris Therapeutics, Inc.,
    Dr. Reddys Laboratories Ltd., Bristol - Myers
    Squibb, Pfizer, Inc., Clinuvel Pharmaceuticals
    Ltd., Applied Biology, Inc., and Boston
    Pharmaceuticals.

9
Key Development
  • Key players in the market are focused on adopting
    acquisition strategies to enhance their market
    share, which is expected to augment the market
    growth. For instance, in 2017, Aclaris
    Therapeutics, Inc. acquired Confluence Life
    Sciences, Inc., a company focused on development
    of kinase inhibitors for the treatment of
    autoimmune disorders such as alopecia areata,
    vitiligo, and atopic dermatitis.

10
  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Reference https//www.coherentmarketinsights.com
    /market-insight/vitiligo-drugs-market-2447

11
About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions.
  • What we provide
  • Customized Market Research Services
  • Industry Analysis Services
  • Business Consulting Services
  • Market Intelligence Services
  • Long term Engagement Model
  • Country Specific Analysis

12
Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt.Ltd.
  • Address 1001 4th Ave, 3200 Seattle, WA 98154,
    U.S.
  • Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

13
  • Thank You!
  • Kindly follow CMI Social Media Profiles
    for the latest company updates
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
About PowerShow.com